Beximco Pharmaceuticals Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BXP.L research report →
Companywww.beximcopharma.com
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmaceutical ingredients in Bangladesh. The company offers allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It provides its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids.
- CEO
- Iqbal U. Ahmed
- IPO
- 2005
- Employees
- 6,000
- HQ
- Dhaka, BD
Price Chart
Valuation
- Market Cap
- $189.60M
- P/E
- 5.35
- P/S
- 0.70
- P/B
- 0.65
- EV/EBITDA
- 3.42
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 44.23%
- Op Margin
- 19.54%
- Net Margin
- 13.13%
- ROE
- 12.72%
- ROIC
- 10.56%
Growth & Income
- Revenue
- $44.39B · 13.05%
- Net Income
- $5.83B · 26.34%
- EPS
- $13.07 · 26.40%
- Op Income
- $8.67B
- FCF YoY
- 81.64%
Performance & Tape
- 52W High
- $52.33
- 52W Low
- $0.42
- 50D MA
- $27.54
- 200D MA
- $37.89
- Beta
- 0.24
- Avg Volume
- 47.38K
Get TickerSpark's AI analysis on BXP.L
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our BXP.L Coverage
We haven't published any research on BXP.L yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BXP.L Report →